Scott A Halperin
Overview
Explore the profile of Scott A Halperin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
276
Citations
3974
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Moss S, Stelfox M, McArthur E, Sriskandarajah C, Ahmed S, Birnie K, et al.
BMC Public Health
. 2024 Feb;
24(1):631.
PMID: 38413913
Background: Children and youth experienced marked impacts on day-to-day life in the COVID-19 pandemic that were associated with poorer familial and friend relationships, and greater mental health challenges. Few studies...
12.
Parsons Leigh J, FitzGerald E, Moss S, Cherak M, Brundin-Mather R, Dodds A, et al.
Hum Vaccin Immunother
. 2024 Feb;
20(1):2316417.
PMID: 38390696
We sought in-depth understanding on the evolution of factors influencing COVID-19 booster dose and bivalent vaccine hesitancy in a longitudinal semi-structured interview-based qualitative study. Serial interviews were conducted between July...
13.
14.
Langley J, Gantt S, Halperin S, Ward B, McNeil S, Ye L, et al.
Vaccine
. 2023 Dec;
42(3):713-722.
PMID: 38142214
Introduction: Cytomegalovirus (CMV) is the most common cause of congenital infection and affected children often have permanent neurodevelopmental sequelae, including hearing loss and intellectual disability. Vaccines to prevent transmission of...
15.
Le Saux N, Bettinger J, Shulha H, Sadarangani M, Coyle D, Booth T, et al.
CMAJ Open
. 2023 Dec;
11(6):E1156-E1163.
PMID: 38114258
Background: Canadian immunization programs for rotavirus started in 2011. We sought to determine their effect on the burden of community-acquired admissions and hospital-acquired rotavirus at pediatric hospitals. Methods: The Canadian...
16.
Modler J, Morris S, Bettinger J, Bancej C, Burton C, Foo C, et al.
Pediatr Infect Dis J
. 2023 Dec;
43(4):301-306.
PMID: 38048641
Background: We aimed to estimate the proportion of children hospitalized for influenza whose illness was complicated by bloodstream infection, describe their clinical course, and identify the factors associated with bloodstream...
17.
Shoukat A, Abdollahi E, Galvani A, Halperin S, Langley J, Moghadas S
Lancet Reg Health Am
. 2023 Nov;
28:100629.
PMID: 38026446
Background: The cost-effectiveness of immunisation strategies with a long-acting monoclonal antibody (nirsevimab) and/or a protein-based maternal vaccine (RSVpreF) for protecting infants from Respiratory Syncytial Virus (RSV)-associated illness has not been...
18.
Bolotin S, Hughes S, Savage R, McLachlan E, Severini A, Arnold C, et al.
PLoS One
. 2023 Nov;
18(11):e0287765.
PMID: 37948389
Objectives: To investigate maternal antibody levels to varicella in infants <12 months of age in Ontario, Canada. Study Design: In this study, we included specimens from infants <12 months of...
19.
Schober T, Morris S, Bettinger J, Burton C, Halperin S, Jadavji T, et al.
Infection
. 2023 Nov;
52(3):865-875.
PMID: 37930625
Purpose: To determine characteristics associated with inappropriate antibiotic use amongst children hospitalised for influenza. Methods: We performed active surveillance for laboratory-confirmed influenza hospitalizations amongst children ≤ 16 years old at...
20.
Abu-Raya B, Esser M, Nakabembe E, Reine J, Amaral K, Diks A, et al.
J Mol Biol
. 2023 Nov;
435(24):168344.
PMID: 37926426
Neither immunization nor recovery from natural infection provides life-long protection against Bordetella pertussis. Replacement of a whole-cell pertussis (wP) vaccine with an acellular pertussis (aP) vaccine, mutations in B. pertussis...